Log In
Print this Print this

Prevasol (PRV-001)

  Manage Alerts
Collapse Summary General Information
Company Prevacus Inc.
DescriptionNeurosteroid administered through the nasal cavity
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationShock / trauma
Indication DetailsTreat mild traumatic brain injury (TBI)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today